210. 単心室症 Single Ventricle Clinical trials / Disease details
臨床試験数 : 49 / 薬物数 : 53 - (DrugBank : 23) / 標的遺伝子数 : 32 - 標的パスウェイ数 : 67
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02975999 (ClinicalTrials.gov) | December 2016 | 22/9/2016 | Use of Vasopressin Following the Fontan Operation | Use of Vasopressin Following the Fontan Operation: Both Pilot and Multicenter Studies | Pleural Effusion;Single-ventricle | Drug: Vasopressin;Drug: Normal Saline | Advocate Health Care | NULL | Suspended | 18 Months | 7 Years | All | 84 | Phase 2/Phase 3 | United States |